Pulmatrix, Inc. — Director's Dealing 2015

Jun 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmatrix, Inc. (PULM)
CIK: 0001574235
Period of Report: 2015-06-15

Reporting Person: Hava David L. (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-15	Common Stock	A	4863	—	Acquired	4863	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-15	Stock Option (Right to Buy)	$2.20	A	3555	Acquired	2020-02-10	Common Stock (3555)	Direct
2015-06-15	Stock Option (Right to Buy)	$2.20	A	804	Acquired	2020-05-24	Common Stock (804)	Direct
2015-06-15	Stock Option (Right to Buy)	$2.20	A	2668	Acquired	2021-02-03	Common Stock (2668)	Direct
2015-06-15	Stock Option (Right to Buy)	$2.20	A	2964	Acquired	2021-06-15	Common Stock (2964)	Direct
2015-06-15	Stock Option (Right to Buy)	$2.03	A	5928	Acquired	2022-06-08	Common Stock (5928)	Direct
2015-06-15	Stock Option (Right to Buy)	$2.03	A	11855	Acquired	2022-06-08	Common Stock (11855)	Direct
2015-06-15	Stock Option (Right to Buy)	$2.03	A	13041	Acquired	2022-12-14	Common Stock (13041)	Direct
2015-06-15	Stock Option (Right to Buy)	$1.88	A	14819	Acquired	2023-08-26	Common Stock (14819)	Direct
2015-06-16	Stock Option (Right to Buy)	$11.80	A	267129	Acquired	2025-06-16	Common Stock (267129)	Direct

Footnotes

F1: Reflects a 1-for-2.5 reverse stock split effected on June 15, 2015.

F2: On June 15, 2015, the Reporting Person received these shares of the Issuer's Common Stock in exchange for securities of a private company formerly known as Pulmatrix, Inc. (the "Former Entity") in connection with the merger of the Former Entity into the Issuer (the "Merger").

F3: These securities were received in the Merger in exchange for a stock option to acquire 59,965 shares for $0.13 per share of common stock of the Former Entity.

F4: These options are fully vested and exercisable.

F5: These securities were received in the Merger in exchange for a stock option to acquire 13,566 shares for $0.13 per share of common stock of the Former Entity.

F6: These securities were received in the Merger in exchange for a stock option to acquire 45,000 shares for $0.13 per share of common stock of the Former Entity.

F7: These options vested/vest over a four-year period, with 25% vesting on the first anniversary of the initial date of grant by the Former Entity and 2.083% vesting each month thereafter for thirty-six months.

F8: These securities were received in the Merger in exchange for a stock option to acquire 50,000 shares for $0.13 per share of common stock of the Former Entity.

F9: These securities were received in the Merger in exchange for a stock option to acquire 100,000 shares for $0.12 per share of common stock of the Former Entity.

F10: These securities were received in the Merger in exchange for a stock option to acquire 200,000 shares for $0.12 per share of common stock of the Former Entity.

F11: These securities were received in the Merger in exchange for a stock option to acquire 220,000 shares for $0.12 per share of common stock of the Former Entity.

F12: These securities were received in the Merger in exchange for a stock option to acquire 250,000 shares for $0.11 per share of common stock of the Former Entity.

F13: These options vested/vest over a four-year period, with 50% vesting on the first anniversary of the initial date of grant by the Former Entity and 4.167% vesting each month thereafter for twelve months.

F14: The option vests as to 2.08% monthly for 48 months from the date of grant.